MyFinsight
Home
Blog
About
Contact
Download
Download image
Licensing
$205,567
Manufacturing
$31,383,684
Total revenue
$31,589,251
Interest income
$83,602
Change in fair value of
derivative financial...
$11,817,375
Gross profit
$12,953,175
Cost of
manufacturing
$18,636,076
Other income
(expense), net
$11,820,773
Income from operations
$9,012,943
Interest expense and
amortization of debt issuance...
$80,204
Total operating
expenses
$3,940,232
Income (loss) before
income taxes
$20,833,716
Depreciation and
amortization
$388,135
Non-cash compensation
through issuance of...
$45,096
General and
administrative
$2,466,336
Research and development
$1,040,665
Net income (loss)
$18,593,806
Income tax expense
$2,239,910
Back
Back
Income Statement
source: myfinsight.com
ELITE PHARMACEUTICALS INC NV (ELTP)
ELITE PHARMACEUTICALS INC NV (ELTP)